(0.19%) 5 027.70 points
(0.25%) 37 997 points
(0.43%) 15 673 points
(-0.39%) $78.69
(3.21%) $1.994
(-0.51%) $2 299.20
(-0.37%) $26.65
(-0.07%) $954.25
(0.36%) $0.936
(0.51%) $11.09
(0.33%) $0.801
(-1.49%) $91.87
@ $2.30
Išleistas: 13 vas. 2024 @ 22:50
Grąža: 11.52%
Ankstesnis signalas: vas. 13 - 22:07
Ankstesnis signalas:
Grąža: 2.22 %
Live Chart Being Loaded With Signals
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide...
Stats | |
---|---|
Šios dienos apimtis | 105 404 |
Vidutinė apimtis | 2.25M |
Rinkos kapitalizacija | 982.52M |
EPS | $0 ( 2024-02-28 ) |
Kita pelno data | ( $-0.0900 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.73 |
ATR14 | $0.00800 (0.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Egholm Michael | Sell | 102 564 | Common Stock |
2024-04-05 | Egholm Michael | Buy | 212 126 | Common Stock |
2024-04-04 | Egholm Michael | Buy | 196 512 | Common Stock |
2024-04-04 | Egholm Michael | Sell | 196 512 | Restricted Stock Units |
2024-01-05 | Egholm Michael | Buy | 9 006 | Common Stock |
INSIDER POWER |
---|
95.25 |
Last 92 transactions |
Buy: 94 395 665 | Sell: 4 412 251 |
Tūris Koreliacija
Standard BioTools Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
CHMA | 0.925 |
DSPG | 0.896 |
JSPR | 0.891 |
ACAD | 0.883 |
CIH | 0.88 |
SPRB | 0.879 |
LIVE | 0.873 |
ARBK | 0.871 |
CTIB | 0.869 |
NTUS | 0.869 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
XPDI | -0.901 |
ODT | -0.878 |
TCDA | -0.877 |
ATAI | -0.871 |
EYEG | -0.868 |
VERA | -0.868 |
PROC | -0.86 |
HECCU | -0.856 |
ENPH | -0.85 |
BCAB | -0.832 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Standard BioTools Inc. Koreliacija - Valiuta/Žaliavos
Standard BioTools Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $106.34M |
Bruto pelnas: | $50.45M (47.44 %) |
EPS: | $-0.940 |
FY | 2023 |
Pajamos: | $106.34M |
Bruto pelnas: | $50.45M (47.44 %) |
EPS: | $-0.940 |
FY | 2022 |
Pajamos: | $97.95M |
Bruto pelnas: | $37.05M (37.83 %) |
EPS: | $-2.43 |
FY | 2021 |
Pajamos: | $130.58M |
Bruto pelnas: | $69.37M (53.13 %) |
EPS: | $-0.767 |
Financial Reports:
No articles found.
Standard BioTools Inc.
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.